Therapy ‐Related Acute Myeloid Leukaemia and Myelodysplastic Syndrome in Victoria, Australia 2003‐2014
ConclusionsThe burden of tAML/tMDS in Victoria is likely to be underestimated. Linkage between VCR and clinical registries is needed to provide more accurate insights.
Pei-Li Zhu, Xiu-Qiong Fu, Jun-Kui Li, Anfernee Kai-Wing Tse, Hui Guo, Cheng-Le Yin, Ji-Yao Chou, Ya-Ping Wang, Yu-Xi Liu, Ying-Jie Chen, Muhammad Jahangir Hossen, Yi Zhang, Si-Yuan Pan, Zong-Jie Zhao, Zhi-Ling Yu
Kelvin M. Jones, Balasubramanyam Karanam, Jacqueline Jones-Triche, Maninder Sandey, Henry J. Henderson, Rajeev S. Samant, Samuel Temesgen, Clayton Yates, Deepa Bedi
Marie-France Penet, Balaji Krishnamachary, Flonn é B. Wildes, Yelena Mironchik, Chien-Fu Hung, TC Wu, Zaver M. Bhujwalla
Dr. Susan Slovin discusses how the evolution of therapeutic treatment is occurring in advanced stage prostate cancer Author: vhsimons Added: 12/17/2018
The concept of Precision Therapy in Prostate Cancer treatment will need to rely more heavily on genetic testing Author: vhsimons Added: 12/17/2018
Jiyan Su, Dan Li, Qianjun Chen, Muxia Li, Lu Su, Ting Luo, Danling Liang, Guoxiao Lai, Ou Shuai, Chunwei Jiao, Qingping Wu, Yizhen Xie, Xinxin Zhou
Juan P. Mu ñoz, Diego Carrillo-Beltrán, Víctor Aedo-Aguilera, Gloria M. Calaf, Oscar León, Edio Maldonado, Julio C. Tapia, Enrique Boccardo, Michelle A. Ozbun, Francisco Aguayo
Org. Biomol. Chem., 2018, Accepted Manuscript DOI: 10.1039/C8OB02668H, PaperYong qiang Zhu, Meng Lei, Huayun Feng, Enhe Bai, Hui Zhou, Jia Wang, Yan ru Qin, Hao yang Zhang, Xueyuan Wang, Zhaogang Liu, Ou Hai, Jia Liu A series of novel dipeptidyl boronic acid compounds were designed, synthesized and biologically investigated the inhibition of β5 subunit of 20S proteasome and several compounds showed high activities with the... The content of this RSS Feed (c) The Royal Society of Chemistry
Jun Wang, Zhen-Yu He, Yong Dong, Jia-Yuan Sun, Wen-Wen Zhang, San-Gang Wu
Objective: To investigate the clinical features of 2nd hematological malignancies post to the initial cancer treatment.METHODS: A retrospective study was performed to analyze the available clinical data of 116 patients diagnosed with 2nd hematologic malignancies after treatment of various malignant tumors from June 1998 to June 2018 at Sun Yat-sen University cancer center.RESULTS: The characteristics of the 116 patients diagnosed with 2nd hematological cancer post to initial cancer treatment were indicated as following: 62 males and 54 females. The primary tumor category was grouped as (according to ICD-10 International Di...